re: Ann: Target's Statement in response t... LZA, from DMR's expert report included in todays announcement,
3. Summary Opinion
In our opinion, the Offer made to the Accent shareholders is fair and reasonable to
Accent shareholders not associated with Xingang, in the absence of a superior offer.
Our principal reason for reaching the above opinion is that we have valued the Accent
shares in the range of $0.20 to $0.38 and the Xingang offer of $0.33 per share is toward the
upper end of our valuation range.
- Forums
- ASX - By Stock
- ACS
- Ann: Target's Statement in response to Xingan
ACS
accent resources nl
Add to My Watchlist
0.00%
!
0.8¢

Ann: Target's Statement in response to Xingan, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.785M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 103727 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 103727 | 0.008 |
1 | 437175 | 0.006 |
1 | 400000 | 0.005 |
1 | 500000 | 0.004 |
2 | 867666 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 5000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.21pm 01/07/2025 (20 minute delay) ? |
Featured News
ACS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online